Antiretroviral Therapy for Acute and Chronic HIV Infection
Status:
Recruiting
Trial end date:
2033-06-01
Target enrollment:
Participant gender:
Summary
This is a protocol designed to randomize subjects with acute HIV infection to receive
standard HAART or mega-HAART for subject who are enrolled in SEARCH 010 study (protocol
title: Establish and characterize an acute HIV infection cohort in a Thai high risk
population.
To describe the impact of standard HAART versus mega-HAART initiated during the acute HIV
infection period on immunological and virological outcomes.
Phase:
Phase 3
Details
Lead Sponsor:
South East Asia Research Collaboration with Hawaii
Collaborators:
Gilead Sciences Merck Sharp & Dohme Corp. Pfizer Thai Red Cross AIDS Research Centre ViiV Healthcare
Treatments:
Dolutegravir Efavirenz Emtricitabine Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Tenofovir